Search results
Are Medical Stocks Lagging Axcella Health (AXLA) This Year?
Zacks via Yahoo Finance· 8 months agoFor those looking to find strong Medical stocks, it is prudent to search for companies in the group...
Axcella Health Inc. (AXLA) Loses 47.9% in 4 Weeks, Here's Why a Trend Reversal May be Around the...
Zacks via Yahoo Finance· 1 year agoAxcella Health Inc. (AXLA) is technically in oversold territory now, so the heavy selling pressure...
Great news for Axcella Health Inc. (NASDAQ:AXLA): Insiders acquired stock in large numbers last year
Simply Wall St. via Yahoo Finance· 2 years agoWhen a single insider purchases stock, it is typically not a major deal. However, when multiple...
Institutions profited after Axcella Health Inc.'s (NASDAQ:AXLA) market cap rose US$35m last week...
Simply Wall St. via Yahoo Finance· 2 years agoIf you want to know who really controls Axcella Health Inc. (NASDAQ:AXLA), then you'll have to look...
Axcella (AXLA) Up on Patent Grant for Long Covid Fatigue Drug
Zacks via Yahoo Finance· 8 months agoAxcella (AXLA) shares surge 299% after the company secures a methods-of-use patent for its lead...
Axcella (AXLA) Up on Decision to Prioritize Long-COVID Program
Zacks via Yahoo Finance· 2 years agoAxcella (AXLA) re-prioritizes its clinical portfolio to focus on the development of AXA1125...
The Zacks Analyst Blog Highlights Absci Axcella Health, Freeline Therapeutics Holdings, DICE...
Zacks via Yahoo Finance· 2 years agoFor Immediate Release Chicago, IL – August 10, 2022 – Zacks.com announces the list of stocks...
3 Pharma Stocks to Dump Before the Damage Is Done
InvestorPlace via Yahoo Finance· 7 months agoPharma stocks and the biotech sector can offer explosive gains. It also offers incredibly crushing defeats in which share prices decline precipitously....
Beware! 3 Biotech Stocks Waving Massive Red Flags Right Now
InvestorPlace via Yahoo Finance· 8 months agoThe biotech sector never fails to offer up stocks full of massive issues at any given time....
Axcella Shares Jump Despite Mixed Bag Data From Mid-Stage NASH Trial
Benzinga via Yahoo Finance· 2 years agoAxcella Therapeutics (NASDAQ: AXLA) reported interim results from its ongoing global Phase 2b...
